miR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1 in a mouse model [83], while miR-221 and 222 enhance cellular migration through activation of the AKT pathway [84]. This evidence concerns the gene FLT1 and lung adenocarcinoma.